Introduction
============

Pediatric osteomyelitis and septic arthritis are severe infections, and diagnostic delay is associated with poor outcomes \[[@fms044-B1; @fms044-B2; @fms044-B3]\]. The incidence of pediatric osteomyelitis varies from 2.9 to 75 cases/100 000 individuals, and that of septic arthritis varies from 5 to 37 \[[@fms044-B4; @fms044-B5; @fms044-B6; @fms044-B7; @fms044-B8; @fms044-B9]\]. Unlike the increasing incidence of bone infection, the incidence of joint infection appears to be stable \[[@fms044-B10; @fms044-B11; @fms044-B12]\].

Specific data on pediatric osteoarticular infections from resource-limited Asian countries, such as Cambodia, are sparse \[[@fms044-B13; @fms044-B14; @fms044-B15; @fms044-B16; @fms044-B17; @fms044-B18; @fms044-B19]\]. Risk factors such as malnutrition, trauma and suboptimal vaccine coverage are widespread \[[@fms044-B20; @fms044-B21; @fms044-B22]\]. Diagnostic microbiology facilities are limited, and antimicrobial resistance is common \[[@fms044-B23]\]. This study characterized the epidemiology of osteoarticular infections in Cambodian children aged \<16 years attending Angkor Hospital for Children (AHC), Siem Reap.

Material and Methods
====================

Cases from January 2007--July 2011 were identified through hospital and laboratory records. Data collected included age, gender, residence, admission details, comorbidities, clinical presentation, laboratory investigations, surgical interventions, antibiotic treatment and outcomes. Weight-for-age *Z*-scores were calculated for children aged \<5 years \[[@fms044-B24]\].

Disease episodes were defined as single treatment episodes, and relapses as recurrent disease episodes following improvement. Monoarticular septic arthritis described single joint infections; single-limb osteomyelitis included adjacent infected long bones within a limb and bone-plus-adjacent-joint involvement, and multisite infections included non-adjacent sites of infection, and/or non-musculoskeletal sites. Mandibular/foot infections were considered separately.

Data were analyzed using Stata 11.1 (StataCorp, TX, USA). Fisher's exact and Kruskal--Wallis tests were used for comparisons between groups for categorical and continuous variables, respectively. Multivariable logistic regression was used to assess risk factors for binary outcomes.

Ethical approval was granted by the AHC Institutional Review Board and the Oxford Tropical Research Ethics Committee, UK.

Results
=======

Of 81 patients, 60 (74%) had a single episode of osteoarticular infection, and 21 had primary episodes followed by relapse(s). The median age (range) was 7.3 years (0--14); boys were almost twice as commonly afflicted. Trauma was seen in 56% of cases, 41% of which was penetrating. Where vaccination status was known, 52 (74%) children had received age-appropriate vaccinations. Five of 23 (22%) under-5 s were moderately to severely undernourished.

For primary episodes, details across clinical categories and symptoms are represented in [Tables 1](#fms044-T1){ref-type="table"} and [2](#fms044-T2){ref-type="table"}. There were no significant differences in white cell count (WCC), ESR or CRP between clinical groups. Crude incidence for non-relapses was 13.8/100 000 attendances; temporal changes by clinical group are depicted in [Fig. 1](#fms044-F1){ref-type="fig"}. Median follow-up time (interquartile range \[IQR\]; range) was 28.5 days (0--140; 0--1339). F[ig]{.smallcaps}. 1.Changes in incidence by clinical syndrome, 2007--2010. MSA, monoarticular septic arthritis; OM, single-limb osteomyelitis (includes single-limb osteomyelitis with adjacent joint involvement); MSI, multisite infection. No observed changes were statistically significant. T[able]{.smallcaps} 1Demographic, admission and investigation results associated with clinical syndromesMonoarticular septic arthritis (*n* = 23)Single-limb osteomyelitis with/without adjacent joint infection (*n* = 41)Multisite infections (*n* = 12)*p*-valueMedian age, years (IQR)6.7 (1.1--11.2)6.4 (3.1--9.5)9.25 (6.15--11.85)0.21Male, *n* (%)15 (65)29 (71)5 (42)0.17Median duration of symptoms, days (IQR)5 (2--28)21 (6--45)5.5 (3--6)0.003Positive blood culture, *n* (% of total patients sampled)5 (56)4 (50)10 (91)0.10*Staphylococcus aureus* infection, *n* (%)4 (17)26 (63)12 (100)\<0.001Median length of stay, days (IQR)12 (4--13)13 (8--16)28 (19--40)\<0.001Number admitted to intensive care (%)01 (3)7 (58)\<0.001Median length of stay in intensive care, days (IQR)18.5 (4--10)0.13[^1] T[able]{.smallcaps} 2Symptoms associated with particular clinical syndromesSymptom (%)Monoarticular septic arthritis (*n* = 22)[^a^](#fms044-TF1){ref-type="table-fn"}Single-limb osteomyelitis with/without adjacent joint infection (*n* = 41)Multisite infections (*n* = 12)*p*-valueFever, *n* (%)19 (86)30 (73)11 (100)0.11Bone/joint pain, *n* (%)21 (95)35 (85)10 (91)0.60Decreased movement, *n* (%)18 (82)28 (68)9 (82)0.50Erythema, *n* (%)5 (23)21 (51)7 (64)0.04Swelling, *n* (%)14 (64)37 (90)11 (100)0.009Respiratory, *n* (%)1 (5)3 (7)8 (73)\<0.001[^2][^3]

Many patients sought treatment before attendance at our institution: 48% had been reviewed in a private clinic and/or by traditional healers, and 24% had taken antibiotics.

Monoarticular septic arthritis
------------------------------

Forty-eight percent of cases presented within 5 days of symptom onset; 68% had fever, joint pain and decreased movement. The hip was involved in 43%, and the knee in 39% of cases ([Fig. 2](#fms044-F2){ref-type="fig"}). Microbiological results are presented in [Table 3](#fms044-T3){ref-type="table"}. F[ig]{.smallcaps}. 2.Prevalence of anatomical site involved in osteoarticular infections. MSA, monoarticular septic arthritis; OM, single-limb osteomyelitis (includes single-limb osteomyelitis with adjacent joint involvement); MSI, multisite infection; PIP, proximal interphalangeal joint. T[able]{.smallcaps} 3Demographic and microbiological details for sample-positive monoarticular septic arthritis cases (n = 13)Patient characteristicsAge (years)GenderCausative organismSites of culture positivitySusceptibility resultsBloodSynovial fluidAMPAMCCHLCIPCROERYGENOXAPENSXT11.1F*Haemophilus influenzaeH. influenzae*Gram-negative bacilli on microscopy; no growth on cultureRSSSRS20.7M*H. influenzae*Sample not taken*H. influenzae*SSSSSR314.2M*Streptococcus pyogenes*Gram-positive cocci on microscopy; no growth on culture*S. pyogenes*SSS49.9FBeta-hemolytic streptococcus[^a^](#fms044-TF3){ref-type="table-fn"}Beta-hemolytic streptococcusNegativeSSS59.1F*Salmonella enterica* Typhi*S.* TyphiNegativeRRR[^b^](#fms044-TF4){ref-type="table-fn"}SR611.8F*Staphylococcus aureusS. aureus*Gram-positive cocci on microscopy; no growth on cultureSRSS[^c^](#fms044-TF5){ref-type="table-fn"}RS77.8M*S. aureus*Negative*S. aureus*SSSSRS86.7F*S. aureus*Negative*S. aureus*SSSSRS913.1F*S. aureus*Not done*S. aureus*SRSSRS100.8MUnspecified gram-negative bacillusNot doneGram-negative bacilli on microscopy; no growth on cultureSusceptibility testing not done111.8MMixed growthNot doneNo Gram stain results; Mixed growth of *Enterobacter aerogenes*, *Streptococcus pneumoniae* and an unspeciated gram-negative bacillusSusceptibility testing not done129.1MUnspecified gram-positive bacillusGram-positive bacilli on microscopy; no growth on cultureSusceptibility testing not done1314FUnspecified Gram-positive bacillusGram-positive bacillus on microscopy of two aspirates; growth of unidentified Gram-positive bacillus on cultureSusceptibility testing not done[^4][^5][^6][^7]

Aspiration/drainage was performed in 21 of 22 cases, with 55% having multiple aspirations; five cases required subsequent arthrotomies. Six had arthrotomies without preceding aspiration. The median (IQR) duration of antimicrobial treatment was 27 days (10--29), with 10 days of intravenous treatment. Neither hip joint involvement nor arthrotomy was associated with sequelae (*p* = 0.66, 1.0).

Single-limb osteomyelitis
-------------------------

On presentation, the median (IQR) duration of symptoms was 17.5 days (6--60). Forty-six percent presented acutely (\<14 days of symptoms), 37% subacutely (≥14 ≤90) and 17% with chronic osteomyelitis (\>90). The femur (37% of cases) was most commonly affected ([Fig. 2](#fms044-F2){ref-type="fig"}).

A higher mean admission WCC was associated with acute presentations (21.1 vs. 11.7 × 10^9^/l; *p* \< 0.001). Mean values for WCC, ESR and CRP were non-significantly higher in those with sequelae.

Fifty percent of admission blood cultures were positive. Bacterial pathogens were cultured from 25 bone/pus samples from 37 individuals: 22 with *Staphylococcus aureus* alone (susceptibilities in [Table 4](#fms044-T4){ref-type="table"}), one with *Haemophilus influenzae* and two with mixed infections (one *S. aureus*/*Escherichia coli*; one *S. aureus*/beta-hemolytic streptococcus). No methicillin-resistant *S. aureus* (MRSA) was isolated. One case was positive for acid-fast bacilli on microscopy. T[able]{.smallcaps} 4Antimicrobial susceptibilities of S. aureus isolates in osteomyelitis cases (n = 24)Susceptibility patternNumber of cases (%)Fully susceptible to first line antibiotics[^a^](#fms044-TF6){ref-type="table-fn"}1 (4)Resistant to penicillin9 (38)Resistant to penicillin + erythromycin6 (25)Resistant to penicillin + co-trimoxazole5 (21)Resistant to penicillin + erythromycin + co-trimoxazole2 (8)Resistant to erythromycin1 (4)[^8]

All but two patients had surgery. The median duration of antimicrobial therapy (IQR) was 30 days (25--43) with 12 days of intravenous therapy.

Both mandibular cases were associated with poor dentition; one had health care-associated MRSA osteomyelitis. The three cases with foot osteomyelitis all occurred post-puncture wounds.

Multisite infections
--------------------

Multisite infections were invariably associated with *S. aureus*. They included most cases (7/8) admitted to intensive care and the only fatality.

Sequelae
--------

Excluding foot and mandibular cases, 35 (46%) children had sequelae ([Table 5](#fms044-T5){ref-type="table"}), of which 20 were relapses. The only risk factor for sequelae was the use of antimicrobial therapy for \>30 days \[adjusted odds ratio 6.4 (95% CI 1.6--25.5), *p* = 0.008\]. T[able]{.smallcaps} 5Summary of relapse and outcome data for patients with particular clinical syndromesOutcomeNumber of patients by clinical groupMonoarticular septic arthritisSingle-limb osteomyelitis ± adjacent joint infectionMultisite infectionsOutcomes at final follow-up in patients without relapse (*n* = 56)    Decreased movement (%)3 (13)7 (24)2 (40)    Residual pain (%)01 (3)0    Persistent fever (%)1 (5)00    Fever and decreased movement (%)1 (5)00    Death (%)001 (20)    Considered cured (%)17 (77)21 (72)2 (40)Outcomes at final follow-up in patients with at least one relapse (*n* = 20)    Decreased movement04 \[+1\][^a^](#fms044-TF7){ref-type="table-fn"} (38)2 (33)    Limb swelling02 \[+1\][^a^](#fms044-TF7){ref-type="table-fn"} (24)0    Considered cured1 (100)5 (38)4 (67)[^9][^10]

Of the cases known to have relapsed, 15 relapsed once and five had multiple relapses. Final outcomes are shown in [Table 5](#fms044-T5){ref-type="table"}.

Discussion
==========

This study is one of the larger, recent, single-center series of pediatric osteoarticular infection, and the only study, to our knowledge, from Cambodia. Interstudy comparisons of incidence are difficult, as denominators are frequently different \[[@fms044-B5; @fms044-B6; @fms044-B7], [@fms044-B25]\]; however, osteoarticular infections represent a relatively common surgical problem locally, accounting for approximately 1 in 50 surgical admissions.

*Staphylococcus aureus* was the most commonly cultured pathogen, but MRSA was not a major problem, unlike in other regional studies \[[@fms044-B13], [@fms044-B14]\]. Six percent of cases cultured *H. influenzae*, demonstrating the importance of empirical cover for this in the absence of adequate vaccination.

More than 95% of patients required surgical intervention, and rates of infectious sequelae were high, although we did not find any associations with published risk factors for poor outcomes \[[@fms044-B15], [@fms044-B26]\]. Delays in presentation and inappropriate preliminary treatment are likely to be contributing factors. A further concern is the use of low-dose/low-frequency oral antibiotic regimens in treatment to improve compliance. Studies of suitable regimens in our setting are needed.

Study limitations include incomplete follow-up; this and the sample size have made it unfeasible to model risk factors for relapse. Diverse treatment approaches were used, making it difficult to identify optimal regimens. We did not look for *Kingella kingae*, which is an important pathogen elsewhere \[[@fms044-B27], [@fms044-B28]\]. Nevertheless, we demonstrate relevant features of these infections in Cambodian children, which can be used as a baseline for modifications to treatment approaches and the monitoring of epidemiological trends.
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[^1]: Cases of mandibular (*n* = 2), calcaneal (*n* = 2) and metatarsal osteomyelitis (*n* = 1) have been excluded from this analysis.

[^2]: Cases of mandibular (*n* = 2), calcaneal (*n* = 2) and metatarsal osteomyelitis (*n* = 1) have been excluded from this analysis.

[^3]: ^a^Clinical details not available for one case.

[^4]: Antimicrobial abbreviations as follows: AMP, ampicillin; AMC, co-amoxiclav; CHL, chloramphenicol; CIP, ciprofloxacin; CRO, ceftriaxone; ERY, erythromycin; GEN, gentamicin; OXA, oxacillin; PEN, penicillin; SXT, co-trimoxazole.

[^5]: ^a^Lancefield grouping not done.

[^6]: ^b^Reduced susceptibility to ciprofloxacin.

[^7]: ^c^Methicillin susceptibility inferred from oxacillin susceptibility.

[^8]: ^a^Defined as penicillin, erythromycin, gentamicin, ciprofloxacin, trimethoprim, oxacillin.

[^9]: Cases of mandibular (*n* = 2), calcaneal (*n* = 2) and metatarsal osteomyelitis (*n* = 1) have been excluded from this analysis.

[^10]: ^a^Numbers in square brackets denote status at last visit; however, further follow-up was planned for these two patients beyond the study end period.
